142 related articles for article (PubMed ID: 34591174)
21. Plasma Antiretinal Autoantibody Profiling and Diagnostic Efficacy in Patients With Autoimmune Retinopathy.
Bae SH; Hong HK; Lee JY; Kim MS; Lee CS; Sagong M; Kim SY; Oh BL; Yoon YH; Shin JP; Jo YJ; Joo K; Park SJ; Park KH; Woo SJ
Am J Ophthalmol; 2023 Jan; 245():145-154. PubMed ID: 35853491
[TBL] [Abstract][Full Text] [Related]
22. Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy.
Pawestri AR; Arjkongharn N; Suvannaboon R; Tuekprakhon A; Srimuninnimit V; Udompunthurak S; Atchaneeyasakul LO; Koolvisoot A; Trinavarat A
Sci Rep; 2021 Jul; 11(1):15047. PubMed ID: 34294798
[TBL] [Abstract][Full Text] [Related]
23. ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosa.
Nair AA; Marmor MF
Doc Ophthalmol; 2017 Jun; 134(3):175-183. PubMed ID: 28451987
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal Assessment of Retinal Thinning in Adults With and Without Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography.
Lim JI; Niec M; Sun J; Cao D
JAMA Ophthalmol; 2021 Mar; 139(3):330-337. PubMed ID: 33538815
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune retinopathy in a patient with smoldering multiple myeloma: a case report.
Bergman Z; Mohammed T; Schocket L; Aouchiche R; Johnson MA
Doc Ophthalmol; 2024 Jun; 148(3):167-171. PubMed ID: 38363513
[TBL] [Abstract][Full Text] [Related]
26. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
27. Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases.
Khanna S; Martins A; Oakey Z; Mititelu M
J Ophthalmic Inflamm Infect; 2019 Feb; 9(1):6. PubMed ID: 30806850
[TBL] [Abstract][Full Text] [Related]
28. Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type.
Gerth C; Morel CF; Feigenbaum A; Levin AV
J AAPOS; 2008 Dec; 12(6):591-6. PubMed ID: 18848477
[TBL] [Abstract][Full Text] [Related]
29. An update on autoimmune retinopathy.
Dutta Majumder P; Marchese A; Pichi F; Garg I; Agarwal A
Indian J Ophthalmol; 2020 Sep; 68(9):1829-1837. PubMed ID: 32823399
[TBL] [Abstract][Full Text] [Related]
30. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune Retinopathy.
Tsang SH; Sharma T
Adv Exp Med Biol; 2018; 1085():223-226. PubMed ID: 30578520
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.
Boudreault K; Justus S; Sengillo JD; Schuerch K; Lee W; Cabral T; Tsang SH
Orphanet J Rare Dis; 2017 Jul; 12(1):129. PubMed ID: 28709429
[TBL] [Abstract][Full Text] [Related]
33. Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy.
Fujiwara T; Imamura Y; Giovinazzo VJ; Spaide RF
Retina; 2010 Sep; 30(8):1206-16. PubMed ID: 20661173
[TBL] [Abstract][Full Text] [Related]
34. OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina.
Cunha JP; Proença R; Dias-Santos A; Almeida R; Águas H; Alves M; Papoila AL; Louro C; Castanheira-Dinis A
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1827-1835. PubMed ID: 28643042
[TBL] [Abstract][Full Text] [Related]
35. Non-paraneoplastic related retinopathy: clinical challenges and review.
Takiuti JT; Takahashi VKL; Xu CL; Jauregui R; Tsang SH
Ophthalmic Genet; 2019 Aug; 40(4):293-297. PubMed ID: 31394964
[TBL] [Abstract][Full Text] [Related]
36. Localized retinal manifestations of paraneoplastic autoimmune retinopathy.
Eadie JA; Ip MS; Ver Hoeve JN
Retin Cases Brief Rep; 2014; 8(4):318-21. PubMed ID: 25372537
[TBL] [Abstract][Full Text] [Related]
37. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
38. Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results.
Guy J; Feuer WJ; Davis JL; Porciatti V; Gonzalez PJ; Koilkonda RD; Yuan H; Hauswirth WW; Lam BL
Ophthalmology; 2017 Nov; 124(11):1621-1634. PubMed ID: 28647203
[TBL] [Abstract][Full Text] [Related]
39. Analysis of multiple sclerosis patients with electrophysiological and structural tests.
Hamurcu M; Orhan G; Sarıcaoğlu MS; Mungan S; Duru Z
Int Ophthalmol; 2017 Jun; 37(3):649-653. PubMed ID: 27538913
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.
Kjellström U; Andréasson S; Ponjavic V
Acta Ophthalmol; 2014 Mar; 92(2):149-57. PubMed ID: 23387307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
